Cost-effectiveness of screening for HLA - A *31:01 prior to initiation of carbamazepine in epilepsy (2015)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/epi.12937
PubMed Identifier: 26046144
Publication URI: http://europepmc.org/abstract/MED/26046144
Type: Journal Article/Review
Parent Publication: Epilepsia
Issue: 4
ISSN: 0013-9580